Ketamine for Major Depressive Disorder

NCT03721900 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: SHX-001 Active low dose
DRUG: Placebo
DRUG: SHX-001 Active High dose

Sponsor

Shenox Pharmaceuticals, LLC